Literature DB >> 21940679

The NF-κB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis.

Guobing Chen1, Kristine Hardy, Eloisa Pagler, Lina Ma, Seungsoo Lee, Steve Gerondakis, Stephen Daley, M Frances Shannon.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated autoimmune disease involving effector Th subsets such as Th1 and Th17. In this study, we demonstrate that mice lacking the NF-κB transcription factor family member c-Rel (rel(-/-)), which are known to be resistant to EAE, show impaired Th17 development. Mixed bone marrow chimeras and EAE adoptive transfer experiments show that the deficiency of effector Th17 cells in rel(-/-) mice is T cell intrinsic. Consistent with this finding, c-Rel was activated in response to TCR signaling in the early stages of Th17 development and controlled the expression of Rorc, which encodes the Th17 transcription factor retinoic acid-related orphan receptor γt. CD28, but not IL-2, repression of Th17 development was dependent on c-Rel, implicating a dual role for c-Rel in modulating Th17 development. Adoptive transfer experiments also suggested that c-Rel control of regulatory T cell differentiation and homeostasis influences EAE development and severity by influencing the balance between Th17 and regulatory T cells. Collectively, our findings indicate that in addition to promoting Th1 differentiation, c-Rel regulates the development and severity of EAE via multiple mechanisms that impact on the generation of Th17 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940679     DOI: 10.4049/jimmunol.1101757

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

Review 2.  NF-κB control of T cell development.

Authors:  Steve Gerondakis; Thomas S Fulford; Nicole L Messina; Raelene J Grumont
Journal:  Nat Immunol       Date:  2014-01       Impact factor: 25.606

3.  Impact of the gut microbiota on enhancer accessibility in gut intraepithelial lymphocytes.

Authors:  Nicholas P Semenkovich; Joseph D Planer; Philip P Ahern; Nicholas W Griffin; Charles Y Lin; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-01       Impact factor: 11.205

Review 4.  Genetic requirements for the development and differentiation of interleukin-17-producing γδ T cells.

Authors:  Sandra M Hayes; Renee M Laird
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 5.  Regulation of nuclear factor-κB in autoimmunity.

Authors:  Shao-Cong Sun; Jae-Hoon Chang; Jin Jin
Journal:  Trends Immunol       Date:  2013-02-20       Impact factor: 16.687

Review 6.  Transcriptional regulatory networks for CD4 T cell differentiation.

Authors:  Darah Christie; Jinfang Zhu
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 7.  Diversity of IL-17-producing T lymphocytes.

Authors:  Jiyeon S Kim; Martha S Jordan
Journal:  Cell Mol Life Sci       Date:  2012-10-04       Impact factor: 9.261

8.  c-Rel Regulates Inscuteable Gene Expression during Mouse Embryonic Stem Cell Differentiation.

Authors:  Riki Ishibashi; Satoshi Kozuki; Sachiko Kamakura; Hideki Sumimoto; Fumiko Toyoshima
Journal:  J Biol Chem       Date:  2015-12-22       Impact factor: 5.157

9.  T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation.

Authors:  Luciana L Molinero; Alan Cubre; Carolina Mora-Solano; Ying Wang; Maria-Luisa Alegre
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

10.  c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in mice.

Authors:  Yu Yu; Dapeng Wang; Kane Kaosaard; Chen Liu; Jianing Fu; Kelley Haarberg; Claudio Anasetti; Amer A Beg; Xue-Zhong Yu
Journal:  Eur J Immunol       Date:  2013-07-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.